Eres cliente nuevo?
CELLULAR MATRIX A-CP-HA - EQUIPMED - Tecnología de Vanguardia al Servicio Médico


Synergistically combines the complementary clinical effects of A-PRP and HA to provide added benefit for OA patients. 
A-PRP: the patient’s platelet concentrate prepared with CellularMatrix, provides an autologous resevoir of growth factors from the patient’s blood.
​Platelets are key factors in hard and soft tissue repair mechanisms. They provide essential growth factors, such as FGF, PDGF, TGF-ß, EGF, VEGF, IGF, which are involved in stem cell migration, differentiation and proliferation. Additionally,platelets also stimulate fibroblasts and endothelial cells to induce new extracellular matrix deposition and neo-vascularisation respectively.
​Plasma contains many factors essential for cell survival including nutrients, vitamins, hormones, electrolytes, growth factors (such as IGF and HGF), and proteins. Among the plasma proteins, the molecules vital for the coagulation process and for the fibrin polymer formation will serve as a scaffold for cell migration and new tissue generation.
- Proven role in the healing of soft and hard tissues, with key actions on cell migration, proliferation and differentiation.
- Growing body of evidence to support the treatment of OA mechanism of action comprises anti-inflammatory activity and activation of cell-signalling cascades.
- Key role in new matrix synthesis for tissue regeneration.
Hyaluronic Acid (HA) is a major component of synovial fluid contributing to joint homeostasis.
- 25 years of clinical experience show pain relief and functional improvement lasting 6 to 12 months.
- Plays a major role in viscosupplementation and pain relief in OA.
- A network of HA chains constitutes an ideal cell-friendly matrix.